Author:
Boyle Leah,Lawrenson Ross,Nosa Vili,Campbell Ian,Tin Tin Sandar
Abstract
Abstract
Purpose
Aotearoa/New Zealand (NZ) faces ethnic inequities with respect to breast cancer survival and treatment. This study establishes if there are ethnic differences in (i) type of surgery and (ii) receipt of radiotherapy (RT) following breast conserving surgery (BCS), among women with early-stage breast cancer in NZ.
Methods
This analysis used Te Rēhita Mate Ūtaetae (Breast Cancer Foundation National Register), a prospectively maintained database of breast cancers from 2000 to 2020. Logistic regression models evaluated ethnic differences in type of surgery (mastectomy or BCS) and receipt of RT with sequential adjustment for potential contributing factors. Subgroup analyses by treatment facility type were undertaken.
Results
Of the 16,228 women included, 74% were NZ European (NZE), 10.3% were Māori, 9.4% were Asian and 6.2% were Pacific. Over one-third of women with BCS-eligible tumours received mastectomy. Asian women were more likely to receive mastectomy than NZE (OR 1.62; 95% CI 1.39, 1.90) as were wāhine Māori in the public system (OR 1.21; 95% CI 1.02, 1.44) but not in the private system (OR 0.78; 95% CI 0.51, 1.21). In women undergoing BCS, compared to NZE, Pacific women overall and wāhine Māori in the private system were, respectively, 36 and 38% less likely to receive RT (respective OR 0.64; 95% CI 0.50, 0.83 and 0.62; 95% CI 0.39, 0.98).
Conclusion
A significant proportion of women with early-stage breast cancer underwent mastectomy and significant ethnic inequities exist. Modern guidelines encourage BCS + RT. In NZ, this outcome must be carefully monitored by ethnicity to facilitate equitable surgical management of early-stage breast cancer.
Funder
Dunedin Basic Medical Sciences Course Trust
Royal Australasian College of Surgeons
Post MSc Research Assistant position at The University of Oxford
HRC and Girdlers’ UK fellowship
Sir Charles Hercus Health Research Fellowship
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
2. International Agency for Research on Cancer (WHO) (2020) New Zealand https://gco.iarc.fr/today/data/factsheets/populations/554-new-zealand-fact-sheets.pdf. Accessed 20 August 2023
3. New Zealand Breast Cancer Foundation (2020) https://www.breastcancerfoundation.org.nz. Accessed 01 July 2023
4. Tin Tin S, Elwood JM, Brown C, Sarfati D, Campbell I, Scott N, Ramsaroop R, Seneviratne S, Harvey V, Lawrenson R (2018) Ethnic disparities in breast cancer survival in New Zealand: which factors contribute? BMC Cancer 18(1):58. https://doi.org/10.1186/s12885-017-3797-0
5. Campbell I, Scott N, Seneviratne S, Kollias J, Walters D, Taylor C, Roder D (2015) Breast cancer characteristics and survival differences between Māori, Pacific and other New Zealand women included in the quality audit program of breast surgeons of Australia and New Zealand. Asian Pac J Cancer Prev 16(6):2465–2472. https://doi.org/10.7314/apjcp.2015.16.6.2465
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献